A Phase II Study on the Toxicity and Efficacy of a Normal Tissue Tolerance Adapted, 5 Fraction Stereotactic Body Radiation Therapy (SBRT) Regimen, for Extra-Cranial Oligometastases
This is a prospective Phase II study.The purpose of this study is to monitor the side
effects and treatment outcomes of delivering higher doses of radiation therapy to the
tumour, while limiting the dose of radiation to the normal tissues. This will be done using
a 5 day treatment schedule.
The characteristics of patients whose disease remains confined to limited areas in the long
term, compared with those who do not will also be described.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society